Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study

Effects of dimethyl fumarate on neuroprotection and immunomodulation

(2012) Philipp Albrecht et al.   Journal of Neuroinflammation

Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab

(2012) T. Button et al.   Multiple Sclerosis Journal

Message from the Editors to our Reviewers

(2012) R. A. Gross et al.   NEUROLOGY

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

(2011) Ralf A. Linker et al.   BRAIN

Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis

(2010) Maria Pia Sormani et al.   Multiple Sclerosis Journal

Measuring Demyelination and Remyelination in Acute Multiple Sclerosis Lesion Voxels

(2009) Paul S. Giacomini et al.   ARCHIVES OF NEUROLOGY

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

(2009) Frederik Barkhof et al.   Nature Reviews Neurology

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

(2008) Jacqueline T. Chen et al.   ANNALS OF NEUROLOGY